Cytosolix
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Cytosolix Information
Geographic Data
Address:
City: Tolland
State: Connecticut
Zip:
Country: United States
Financial Info
Stage:
convertible note
Raised Last:
$230k
Raised Total:$230k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics. Cytosolix&s;s Tumor Activated Permeability System, produces weakly-acidic derivatives of known oncology drugs, that enhance the uptake by cancer cells while restricting the uptake by healthy cells, enabling physicians to get safer and more effective therapy for drugs with dose-limiting toxicities.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2019 | Convertible Note | 1 | $230k |
Connecticut Innovations Connecticut Innovations |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
